ImmunoCAP Rapid is a first-line, point-of-care device for evaluation of patients with allergy-related symptoms. The results are direct, clear and simple. ImmunoCAP Rapid generates a reliable, easy-to-understand IgE profile of both children and adults with symptoms of wheezing and rhinitis. The test result provides direction on further action to take – such as appropriate medication and/or referrals – right in the physician’s office.

ImmunoCAP Rapid is available in Italy, Spain, Sweden, Switzerland, the UK and in the US.